Elevated levels of inflammatory biomarkers, such as C-reactive protein (CRP) [21,22], interleukin-6 (IL-6) [22,23], and tumor necrosis factor-alpha (TNF-alpha) [24] are reported among OSA patients. This evidence concerns the gene IL6 and obstructive sleep apnea syndrome.